Baker Bros. Capital (gp), Llc - Net Worth and Insider Trading
Baker Bros. Capital (gp), Llc Net Worth
The estimated net worth of Baker Bros. Capital (gp), Llc is at least $135 Million dollars as of 2024-04-26. Baker Bros. Capital (gp), Llc is the Director, 10% Owner of Seagen Inc and owns about 481,890 shares of Seagen Inc (SGEN) stock worth over $110 Million. Baker Bros. Capital (gp), Llc is the Director, 10% Owner of Genomic Health Inc and owns about 194,415 shares of Genomic Health Inc (GHDX) stock worth over $12 Million. Baker Bros. Capital (gp), Llc is also the Director, 10% Owner of Incyte Corp and owns about 239,258 shares of Incyte Corp (INCY) stock worth over $12 Million. Besides these, Baker Bros. Capital (gp), Llc also holds BioCryst Pharmaceuticals Inc (BCRX) . Details can be seen in Baker Bros. Capital (gp), Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Baker Bros. Capital (gp), Llc has not made any transactions after 2011-06-09 and currently still holds the listed stock(s).
Transaction Summary of Baker Bros. Capital (gp), Llc
Baker Bros. Capital (gp), Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Baker Bros. Capital (gp), Llc owns 5 companies in total, including Seagen Inc (SGEN) , Heron Therapeutics Inc (HRTX) , and Incyte Corp (INCY) among others .
Click here to see the complete history of Baker Bros. Capital (gp), Llc’s form 4 insider trades.
Insider Ownership Summary of Baker Bros. Capital (gp), Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGEN | Seagen Inc | 2009-08-11 | director & 10 percent owner |
| HRTX | Heron Therapeutics Inc | 2009-10-19 | 10 percent owner |
| INCY | Incyte Corp | 2010-09-23 | director |
| BCRX | BioCryst Pharmaceuticals Inc | 2007-08-06 | 10 percent owner |
| ACGN | Aceragen Inc | 2006-03-24 | 10 percent owner |
Baker Bros. Capital (gp), Llc Latest Holdings Summary
Baker Bros. Capital (gp), Llc currently owns a total of 4 stocks. Among these stocks, Baker Bros. Capital (gp), Llc owns 481,890 shares of Seagen Inc (SGEN) as of August 11, 2009, with a value of $110 Million and a weighting of 81.49%. Baker Bros. Capital (gp), Llc owns 194,415 shares of Genomic Health Inc (GHDX) as of June 9, 2011, with a value of $12 Million and a weighting of 9.12%. Baker Bros. Capital (gp), Llc also owns 239,258 shares of Incyte Corp (INCY) as of September 23, 2010, with a value of $12 Million and a weighting of 9.05%. The other 1 stocks BioCryst Pharmaceuticals Inc (BCRX) have a combined weighting of 0.34% among all his current holdings.
Latest Holdings of Baker Bros. Capital (gp), Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2009-08-11 | 481,890 | 228.74 | 110,227,519 |
| GHDX | Genomic Health Inc | 2011-06-09 | 194,415 | 63.44 | 12,333,688 |
| INCY | Incyte Corp | 2010-09-23 | 239,258 | 51.18 | 12,245,224 |
| BCRX | BioCryst Pharmaceuticals Inc | 2007-08-06 | 109,241 | 4.16 | 454,443 |
Holding Weightings of Baker Bros. Capital (gp), Llc
Baker Bros. Capital (gp), Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Baker Bros. Capital (gp), Llc has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the acquisition of 798 shares on August 11, 2009, which cost Baker Bros. Capital (gp), Llc around $8,579.
According to the SEC Form 4 filings, Baker Bros. Capital (gp), Llc has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the acquisition of 119 shares on June 9, 2011, which cost Baker Bros. Capital (gp), Llc around $3,117.
According to the SEC Form 4 filings, Baker Bros. Capital (gp), Llc has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 32,388 shares on September 23, 2010, which brought Baker Bros. Capital (gp), Llc around $481,933.
More details on Baker Bros. Capital (gp), Llc's insider transactions can be found in the Insider Trading History of Baker Bros. Capital (gp), Llc table.Insider Trading History of Baker Bros. Capital (gp), Llc
- 1
Baker Bros. Capital (gp), Llc Trading Performance
GuruFocus tracks the stock performance after each of Baker Bros. Capital (gp), Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Baker Bros. Capital (gp), Llc is 9.15%. GuruFocus also compares Baker Bros. Capital (gp), Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Baker Bros. Capital (gp), Llc within 3 months outperforms 31 times out of 49 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Baker Bros. Capital (gp), Llc's insider trading performs compared to the benchmark.
Performance of Baker Bros. Capital (gp), Llc
Average Return
15.08%
Outperforming Transactions
59%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.53 | 9.15 | 19.59 | 15.08 | 18.66 | 20.17 |
| Relative Return to S&P 500(%) | 5.15 | 7.25 | 17.62 | 22.7 | 20.12 | 17.92 |
Baker Bros. Capital (gp), Llc Ownership Network
Ownership Network List of Baker Bros. Capital (gp), Llc
Ownership Network Relation of Baker Bros. Capital (gp), Llc
Baker Bros. Capital (gp), Llc Owned Company Details
What does Seagen Inc do?
Who are the key executives at Seagen Inc?
Baker Bros. Capital (gp), Llc is the director & 10 percent owner of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .
Seagen Inc (SGEN) Insider Trades Summary
Over the past 18 months, Baker Bros. Capital (gp), Llc made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,447 shares made by Jean I Liu , a net sale of 46,232 shares made by Roger D Dansey , and a net sale of 161,013 shares made by Todd E Simpson .
In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 413,479 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 413,479 shares.
Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seagen Inc Insider Transactions
Baker Bros. Capital (gp), Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Baker Bros. Capital (gp), Llc. You might contact Baker Bros. Capital (gp), Llc via mailing address: 667 Madison Ave, 21st Floor, New York Ny 10065.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
